News

What a brutal six months it’s been for JELD-WEN. The stock has dropped 61.7% and now trades at $6.11, rattling many shareholders. This might have investors contemplating their next move.

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Royalty Pharma (NASDAQ:RPRX) and the rest of the branded pharmaceuticals stocks fared in Q4.

As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the beverages, alcohol, and tobacco industry, including Celsius (NASDAQ:CELH) and its peers.

As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the agricultural machinery industry, including Deere (NYSE:DE) and its peers.

Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at Chart (NYSE:GTLS) and its peers.

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking at traditional fast food stocks, starting with Wendy's (NASDAQ:WEN).

Wrapping up Q4 earnings, we look at the numbers and key takeaways for the heavy transportation equipment stocks, including Wabash (NYSE:WNC) and its peers.

Since September 2024, Red Robin has been in a holding pattern, posting a small loss of 3% while floating around $4.25.

Although the S&P 500 is down 1.4% over the past six months, Tennant’s stock price has fallen further to $84.99, losing shareholders 9% of their capital. This was partly due to its softer quarterly results and might have investors contemplating their next move.

NeoGenomics has gotten torched over the last six months - since September 2024, its stock price has dropped 36.8% to $9.98 per share. This may have investors wondering how to approach the situation.